Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia-Reference-Cited by-同舟云学术

Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia

Published:2021 Issue:4 Volume:68 Page:477-484
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yuno Akiko¹,Kenmotsu Yoshiyuki¹,Takahashi Yuka²,Nomoto Hiroshi²,Kameda Hiraku²,Cho Kyu Yong²,Nakamura Akinobu²,Yamashita Yu³,Nakamura Junichi³,Nakakubo Sho³,Kamada Keisuke³,Suzuki Masaru³,Sugino Hirokazu⁴,Inoshita Naoko⁵,Konno Satoshi³,Miyoshi Hideaki⁶,Atsumi Tatsuya²,Sawamura Yutaka⁷,Shimatsu Akira⁸

Affiliation:

1. Department of Internal Medicine, Kin-ikyo Chuo Hospital, Sapporo 007-8505, Japan

2. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8648, Japan

3. Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan

4. Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo 060-8648, Japan

5. Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan

6. Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo 060-8648, Japan

7. Sawamura Neurosurgery Clinic, Sapporo 060-0807, Japan

8. Advanced Medical Care Center, Kusatsu General Hospital, Kusatsu 525-8585, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/68/4/68_EJ20-0613/_pdf

Reference27 articles.

1. 1 Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, et al. (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective. Pituitary 23: 327–337.

2. 2 Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, et al. (2020) COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol 8: 654–656.

3. 3 Newell-Price J, Nieman LK, Reincke M, Tabarin A (2020) Endocrinology in the time of COVID-19: management of Cushing’s syndrome. Eur J Endocrinol 183: G1–G7.

4. 4 Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, et al. (2020) The impact of SARS-CoV-2 virus infection on the endocrine system. J Endocr Soc 4: bvaa082.

5. 5 Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, et al. (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126: 123–135.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary and SARS CoV-2: An unremitting conundrum;Best Practice & Research Clinical Endocrinology & Metabolism;2023-07

2. COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders;Endocrine;2023-06-20

3. The effect of COVID-19 on patients with preexisting autoimmune diseases;Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination;2023

4. New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection;Endocrine Practice;2022-10

5. Pituitary and COVID-19: review;Problems of Endocrinology;2022-07-20